News|Articles|August 1, 2025
How One Neuro Brand Cut Through Prior Auth Barriers
Case study on how a neuro biologic brand leveraged SamaCare’s insights and interventions platform to decrease patient access friction and improve patient starts.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Sanofi Officially Appoints Belén Garijo as Chief Executive Officer Following Shareholder Vote
2
BMS vs. Moderna vs. Pfizer: The RNA Platform Race
3
Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO
4
U.S. Prescription Drug Spending Set to Exceed $1 Trillion in 2026: Report
5